|
Market Closed -
Nasdaq
21:00:00 15/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 87.71 USD | +5.08% |
|
+3.91% | +32.15% |
| 10-14 | DexCom, Inc. Announces Publication Of CONNECT Study Results For Dexcom G7 In The New England Journal Of Medicine | CI |
| 10-13 | Mizuho Adjusts Price Target on DexCom to $100 From $95 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 31.5B | |||||
| 178B | |||||
| 121B | |||||
| 108B | |||||
| 75.7B | |||||
| 64.15B |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
